Meril Life Sciences Unveils Landmark One-Year Results for Myval THV Series at PCR London Valves 2025 At PCR London Valves 2025, Meril Life Sciences released one-year findings from the LANDMARK study, comparing Myval THV with major competitors.

Meril Life Sciences Unveils Landmark One-Year Results for Myval THV Series at PCR London Valves 2025 #London #United_Kingdom #Meril_Life_Sciences #Myval_THV #LANDMARK_Study

Meril Life Sciences Reports Landmark One-Year Results for THV Valve Technology at PCR London Valves 2025 At the prestigious PCR London Valves 2025, Meril Life Sciences shared promising results from the LANDMARK trial, showcasing the Myval THV series' performance.

Meril Life Sciences Reports Landmark One-Year Results for THV Valve Technology at PCR London Valves 2025 #London #United_Kingdom #Meril_Life_Sciences #Myval_THV #LANDMARK_Trial

Meril Life Sciences Reveals One-Year Results from LANDMARK Trial at PCR London Valves 2025 At PCR London Valves 2025, Meril Life Sciences shared significant findings from the LANDMARK trial, highlighting the Myval THV valve's performance against competitors.

Meril Life Sciences Reveals One-Year Results from LANDMARK Trial at PCR London Valves 2025 #London #United_Kingdom #Meril_Life_Sciences #LANDMARK_Trial #Myval

Meril Life Sciences Unveils Breakthrough Results from LANDMARK Study at EuroPCR 2025 At EuroPCR 2025, Meril Life Sciences revealed one-year findings from the pivotal LANDMARK study, marking a significant achievement in heart valve research.

Meril Life Sciences Unveils Breakthrough Results from LANDMARK Study at EuroPCR 2025 #India #Meril_Life_Sciences #Vapi #Myval_THV #LANDMARK_Study

Meril Life Sciences Unveils Influential LANDMARK Trial Insights at EuroPCR 2025 Meril Life Sciences revealed pivotal one-year outcomes from their groundbreaking LANDMARK trial at the EuroPCR 2025, showcasing significant advancements in TAVI technology.

Meril Life Sciences Unveils Influential LANDMARK Trial Insights at EuroPCR 2025 #India #Meril_Life_Sciences #Vapi #Myval_THV #LANDMARK_Trial

Meril Life Sciences Achieves Major Milestone with LANDMARK RCT Results Presented at EuroPCR 2025 Meril Life Sciences showcased significant results from their LANDMARK trial at EuroPCR 2025, highlighting the Myval THV's safety and efficacy in TAVI.

Meril Life Sciences Achieves Major Milestone with LANDMARK RCT Results Presented at EuroPCR 2025 #India #Meril_Life_Sciences #Vapi #Myval_THV #LANDMARK_RCT

Meril Introduces Myval Octapro THV to Advance Cardiac Treatment at Global Conferences Meril, a leader in cardiovascular solutions, unveils its groundbreaking Myval Octapro THV at GISE 2024 and PCR London Valves 2024, enhancing transcatheter technology.

Meril Introduces Myval Octapro THV to Advance Cardiac Treatment at Global Conferences #India #Myval_Octapro #Cardiac_Solutions #Meril_Life_Sciences #Vapi